These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11870808)

  • 1. Assessment and monitoring in clinical trials when survival curves have distinct shapes: a Bayesian approach with Weibull modelling.
    Lecoutre B; Mabika B; Derzko G
    Stat Med; 2002 Mar; 21(5):663-74. PubMed ID: 11870808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comment on generic anti-arrhythmic drugs.
    Mason G
    Cardiovasc J S Afr; 2002; 13(3):132. PubMed ID: 12193967
    [No Abstract]   [Full Text] [Related]  

  • 3. Bayesian predictive approach to interim monitoring in clinical trials.
    Dmitrienko A; Wang MD
    Stat Med; 2006 Jul; 25(13):2178-95. PubMed ID: 16007570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian estimation of cost-effectiveness from censored data.
    Heitjan DF; Kim CY; Li H
    Stat Med; 2004 Apr; 23(8):1297-309. PubMed ID: 15083484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amiodarone in high-risk post-infarction patients, Lessons from EMIAT and CAMIAT. European Myocardial Infarct Amiodarone Trial and Canadian Amiodarone Myocardial Infarction Arrhythmia Trial.
    Gambhir DS
    Indian Heart J; 1996; 48(4):339-41. PubMed ID: 8908817
    [No Abstract]   [Full Text] [Related]  

  • 6. Bayesian monitoring of clinical trials with failure-time endpoints.
    Rosner GL
    Biometrics; 2005 Mar; 61(1):239-45. PubMed ID: 15737099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone: a substudy of EMIAT (The European Myocardial Infarct Amiodarone Trial).
    Malik M; Camm AJ; Janse MJ; Julian DG; Frangin GA; Schwartz PJ
    J Am Coll Cardiol; 2000 Apr; 35(5):1263-75. PubMed ID: 10758969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian inference of the Weibull model based on interval-censored survival data.
    Guure CB; Ibrahim NA; Adam MB
    Comput Math Methods Med; 2013; 2013():849520. PubMed ID: 23476718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative Framework for Retrospective Assessment of Interim Decisions in Clinical Trials.
    Stanev R
    Med Decis Making; 2016 Nov; 36(8):999-1010. PubMed ID: 27353825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons from antiarrhythmic trials involving class III antiarrhythmic drugs.
    Yap YG; Camm AJ
    Am J Cardiol; 1999 Nov; 84(9A):83R-89R. PubMed ID: 10568665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis of invasive and noninvasive tests in high risk patients treated with amiodarone after acute myocardial infarction.
    Pedretti RF; Migliori GB; Mapelli V; Daniele G; Podrid PJ; Tramarin R
    J Am Coll Cardiol; 1998 Jun; 31(7):1481-9. PubMed ID: 9626823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of high- and low-dose amiodarone on mortality, left ventricular remodeling, and hemodynamics in rats with experimental myocardial infarction.
    Hu K; Gaudron P; Ertl G
    J Cardiovasc Pharmacol; 2004 Dec; 44(6):627-30. PubMed ID: 15550779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian versus frequentist hypotheses testing in clinical trials with dichotomous and countable outcomes.
    Zaslavsky BG
    J Biopharm Stat; 2010 Sep; 20(5):985-97. PubMed ID: 20721786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian approach to noninferiority trials for proportions.
    Gamalo MA; Wu R; Tiwari RC
    J Biopharm Stat; 2011 Sep; 21(5):902-19. PubMed ID: 21830922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of cordarone in acute myocardial infarct].
    Gol'dberg GA; Nesterov IuI
    Kardiologiia; 1982 Oct; 22(10):107-8. PubMed ID: 6757520
    [No Abstract]   [Full Text] [Related]  

  • 16. Poor adherence to placebo or amiodarone therapy predicts mortality: results from the CAMIAT study. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial.
    Irvine J; Baker B; Smith J; Jandciu S; Paquette M; Cairns J; Connolly S; Roberts R; Gent M; Dorian P
    Psychosom Med; 1999; 61(4):566-75. PubMed ID: 10443767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ventricular cardiac arrhythmias. New anti-arrhythmia agents].
    Scholz H
    Z Kardiol; 1996; 85 Suppl 6():91-6. PubMed ID: 9064988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A practical guide to Bayesian group sequential designs.
    Gsponer T; Gerber F; Bornkamp B; Ohlssen D; Vandemeulebroecke M; Schmidli H
    Pharm Stat; 2014; 13(1):71-80. PubMed ID: 24038922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Bayesian predictive sample size selection design for single-arm exploratory clinical trials.
    Teramukai S; Daimon T; Zohar S
    Stat Med; 2012 Dec; 31(30):4243-54. PubMed ID: 22807115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Amiodarone Trials Meta-Analysis Investigators.
    Lancet; 1997 Nov; 350(9089):1417-24. PubMed ID: 9371164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.